HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients.

Abstract
The clinical characteristics and the results of mineral fibre and cytogenetic analyses were coordinated prospectively for 41 patients with confirmed malignant pleural mesothelioma. A correlation was found between high total fibre concentration, and partial or total loss of chromosomes 1, 4 and 9 and chromosomal rearrangements involving a breakpoint at 1p11-p22. There was also a correlation between crocidolite/amosite as the main fibre type and partial or total loss of chromosomes 1, 3 and 4 and chromosomal rearrangements involving del (3p). Positive prognostic factors were female gender, low total fibre concentration (less than 10(6) fibres per g dried lung tissue), anthophyllite as the main fibre type and normal chromosome 7. In addition, we found 4 patients with malignant mesothelioma who had been exposed mainly to anthophyllite fibres (total lung fibre concentrations of 1.2, 0.4, 0.2 and 0.1 x 10(6) fibres per g dried lung tissue). This would seem to indicate that there may be a carcinogenic role for anthophyllite.
AuthorsL Tammilehto, T Tuomi, M Tiainen, J Rautonen, S Knuutila, S Pyrhönen, K Mattson
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 28A Issue 8-9 Pg. 1373-9 ( 1992) ISSN: 0959-8049 [Print] England
PMID1325175 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Asbestos, Amphibole
  • Asbestos, Crocidolite
  • Asbestos, Amosite
  • Asbestos
  • anthophyllite
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Asbestos (adverse effects)
  • Asbestos, Amosite
  • Asbestos, Amphibole
  • Asbestos, Crocidolite
  • Chromosome Aberrations
  • Chromosome Disorders
  • Chromosomes, Human, Pair 7
  • Female
  • Humans
  • Karyotyping
  • Male
  • Mesothelioma (genetics, mortality, pathology)
  • Middle Aged
  • Pleural Neoplasms (genetics, mortality, pathology)
  • Prognosis
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: